Becker's Healthcare July 18, 2025
In collaboration with Omnicell

IV robotics and workflow preparation technology is critical to the advancement of patient safety and accuracy in IV compounding. But while the need is widely recognized, barriers to adoption – including tight budgets, bandwidth constraints, and lack of regulations or requirements – continue to persist.

Industry leaders, patient safety advocates, and policy activists gathered in Pittsburgh last month for the IV TRUST Summit – an exclusive event intended to further the adoption of IV automation to improve the safety, accuracy, and availability of sterile compounds. Among those leading the charge is Mark Neuenschwander.

No stranger to patient safety advocacy, Neuenschwander has spent more than three decades promoting development and deployment of medication safety technologies. His work to drive adoption of...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Pharma, Pharma / Biotech, Robotics/RPA, Technology
Navigating the Shift: 2026 Medicare Drug Pricing and the Future of Pharmacy
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
Q&A: New PQA Resource Highlights 40 Projects Targeting Social Determinants of Health
NVIDIA and Lilly Announce Co-Innovation AI Lab to Accelerate Drug Discovery
The Future of Pharmacovigilance Technology: How AI and Automation Are Redefining Drug Safety

Share Article